– Focus on Spain and Southern Europe
As a specialized partner in clinical research, Camovis stands for quality, reliability, and a clear focus on the successful execution of clinical trials. Our approach combines operational excellence with a deep understanding of the needs of sponsors, CROs, and study sites—always with the goal of delivering studies efficiently, patient-centered, and sustainably.
🌍 Why Spain and Southern Europe?
Spain is one of the most dynamic markets for clinical research in Europe. High study activity and a growing innovation landscape are making the region increasingly attractive for international projects. At the same time, the demand for experienced, quality-driven partners who can efficiently support studies on the ground and ensure international standards is rising.
With the targeted expansion of our presence, Camovis is responding to this development: we are building additional capacity, strengthening our proximity to local stakeholders, and enabling our partners to execute their studies even more effectively.
👩💼 New responsibility: Expanding our market presence in Southern Europe
Daniela Proaño Miranda will lead the market entry and expansion of our activities in Spain and Southern Europe. As a Senior Professional in clinical research, she combines many years of experience in study management and project leadership with a deep understanding of complex trials. As a native speaker, she provides direct access to local partners, study sites, and networks. Her focus is on building sustainable structures and high-performing networks that connect people, projects, and ways of working—bringing Camovis’ goal to life: delivering clinical trials in new markets efficiently, with assured quality, and in strong partnership.
🤝 Advancing clinical research together
With this step, Camovis reinforces its ambition not only to grow but to actively contribute to the advancement of clinical research in Europe.
👉 Are you planning studies in Spain or Southern Europe, or looking for an experienced local partner?
We look forward to connecting.